UB-854

N/A

Report date: 2025/05/07 14:45:47

Base Information

Drug NameUB-854
Drug Alias NameRecombinant factor IX biobetter重组人类第九凝血因子UB-854
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor IX replacements
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia BRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUbi Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesUbi Pharma Inc
Inactive CompaniesN/A
Active IndicationsHemophilia BRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A